About Peptilogics
Peptilogics is a Healthcare company based in Pittsburgh (United States) founded in 2013. Antibiotics targeting multi-drug resistant bacteria are developed using eCAPS technology. Peptilogics has raised $120.45 million across 13 funding rounds from investors including HHS, CARB-X and Beyond Venture Partners. Peptilogics offers products and services including AI Platform and Peptide Engineering Pipeline. Its focus areas include Life Sciences, Infectious Diseases, Drugs and Diversified. Its legal entity is PEPTILOGICS, INC. Its competitors include Vir Biotechnology, Vaxcyte and Cidara Therapeutics; 3 of its 3 listed competitors have raised funding.
Company details
Peptilogics was founded in 2013 in Pittsburgh, United States, within the biotechnology sector. Novel antibiotics are produced through eCAPS technology, which disrupts bacterial membranes to inactivate multi-drug resistant pathogens. Effectiveness has been demonstrated against ESKAPE pathogens, encompassing both gram-positive and gram-negative strains responsible for most hospital-acquired infections. Operations focus on addressing antibiotic resistance challenges.
- Headquarters Pittsburgh, United States
- SectorsHealthcare
- Email••••••••
- Website peptilogics.com
- Social LinkedIn X YouTube
- Legal Name Peptilogics, Inc.
- Total Equity Funding$120.45M (USD)
in 13 rounds
- Latest Funding Round$78M (USD), Series B
Oct 2025
- InvestorsHHS
& 9 more
Products & Services of Peptilogics
Peptilogics offers a comprehensive portfolio of products and services, including AI Platform and Peptide Engineering Pipeline.
AI system for predictive peptide design and optimization in therapeutics.
Pipeline advancing peptide drugs like PLG0206 for serious diseases.
Apps and channels of Peptilogics
its YouTube channel Peptilogics has 11 subscribers and 3 videos.
Videos from Peptilogics
The most watched videos on Peptilogics's YouTube channel, Peptilogics (11 subscribers). Click a video to play it here.
More on Peptilogics .
Funding Insights of Peptilogics
Peptilogics has successfully raised a total of $120.45M across 13 strategic funding rounds. The most recent funding activity was a Series B round of $78 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $120.45M
- Total Rounds 13
- Last Round Series B — $78M
- First Round $416,761
(Jan 2016)
- Investors Count 10
Latest 10 of 13 funding rounds of Peptilogics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2025 | $78M | Series B | – | Presight Capital, thielbio.com | |
| Jan 2025 | $3.3M | Grant | – | – | |
| Aug 2022 | $499,449 | Grant | – | – | |
| Sep 2021 | $698,722 | Grant | – | – | |
| Jul 2021 | $695,919 | Grant | – | – | |
| Dec 2020 | $35.78M | Series B | – | Presight Capital | |
| Mar 2019 | $347,799 | Grant | – | – | |
| Jan 2019 | $3.54M | Grant | – | – | |
| Sep 2017 | $298,121 | Grant | – | – | |
| Aug 2017 | $5.5M | Series A | – | – |
10 investors in total: 9 institutional and 1 angel.
Investors in Peptilogics
Peptilogics has secured backing from 10 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include HHS, CARB-X and Beyond Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital fund backed by the Christian family office | presight.vc | West Hollywood, United States | ||
Venture capital investments in technology and defense sectors. | foundersfund.com | |||
Investments are made in antimicrobial resistance treatment development. | amractionfund.com | |||
Early-stage investments in technology sectors are provided by Narya. | naryavc.com | Cincinnati, United States | ||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
| bluetreeventurefund.com | ||||
| thielbio.com | ||||
Investment banking services including fundraising, advisory, and mergers and acquisitions. | 2019 | beyondvp.com | Bengaluru, India | |
Antibiotics, vaccines, and diagnostics against drug-resistant bacteria are developed. | 2016 | carb-x.org | Boston, United States | |
PT Peter Thiel | Co-founder of PayPal, early Facebook investor, influential tech angel investor | unknown_b057fe55b82e43b2b |
Investor details for Peptilogics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Peptilogics
15 people are tracked at Peptilogics (8 in leadership, 2 in board & advisors, 5 in team).
| Name | Role | Group |
|---|---|---|
Jonathan Steckbeck | Founder, President & CEO | Leadership |
David Huang | SVP & Chief Medical Officer | Leadership |
Anna Holmes | Director, Clinical Science | Leadership |
Nick Nystrom | SVP & Head of Computation & Data | Leadership |
Bradd Picone | Senior Director of CMC | Leadership |
Dessie Dobbins | Vice President Program Development | Leadership |
Courtney Lonchena | Director Clinical Development | Leadership |
Albert Fonticiella | VP Of People | Leadership |
Dietrich Stephan | Chairman | Board & advisors |
Fabian Hansen | Director | Board & advisors |
Rebecca Lukens | Executive Assistant | Team |
Sarah McMichael | Sr. Manager Product Development | Team |
Karen Corbett | Computational Scientist, Biophysics And Biochemistry | Team |
Michael Jones | Corporate Controller | Team |
Nicholas Pachuda | SVP of Portfolio & Strategy Development | Team |
Complete people profiles for Peptilogics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Peptilogics
3 dated milestones of Peptilogics across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Peptilogics is founded.
- Funding First funding round of $417K.
- Funding Latest funding round, Series B, of $78.0M.
Competitors of Peptilogics
Peptilogics has 3 listed competitors in our database, 3 of them funded. They include Vir Biotechnology, Vaxcyte and Cidara Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| vir.bio | 2017 | San Francisco, United States | $216M | 417 | Developer of therapeutics for the treatment of infectious diseases | |
| vaxcyte.com | 2013 | Foster, United States | $347M | 254 | Vaccines for infectious diseases are developed using cell-free protein synthesis. | |
| cidara.com | 2013 | San Diego, United States | $78.35M | 90 | Novel anti-infectives for bacterial and fungal infections are developed. |
Detailed competitors of Peptilogics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Peptilogics
The website of Peptilogics (peptilogics.com) receives about 2.1K visits a month.
- Monthly visits2.1K
▼ 26.6% vs previous month
Websites whose visitors overlap most with Peptilogics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| novasenta.com | 100% | 2.4K | #6,002,810 | View details | |
| bluespherebio.com | 100% | 2.5K | #6,529,430 | View details | |
| pecalabs.com | 98% | View details | |||
| arielmedicine.com | 98% | 1.3K | #10,684,349 | View details | |
| plexision.com | 98% | 3.2K | #5,846,553 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 13 similar websites and full traffic analytics for Peptilogics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Infectious Diseases
3 companies that operate in the same segment as Peptilogics (Infectious Diseases) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 | |
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Peptilogics
Complete news archive for Peptilogics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Peptilogics
Peptilogics was founded in 2013 and raised its 1st funding round 3 years after it was founded.
Peptilogics is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
Peptilogics is a funded company, having raised a total of $120.45M across 13 funding rounds to date. The company's 1st funding round was a Series A of $5.5M, raised on Jan 2016.
Peptilogics was founded in 2013 in Pittsburgh, United States, within the biotechnology sector. Novel antibiotics are produced through eCAPS technology, which disrupts bacterial membranes to inactivate multi-drug resistant pathogens. Effectiveness has been demonstrated against ESKAPE pathogens, encompassing both gram-positive and gram-negative strains responsible for most hospital-acquired infections. Operations focus on addressing antibiotic resistance challenges.
Peptilogics's top competitors include Vaxcyte, Vir Biotechnology and Cidara Therapeutics.
Peptilogics offers AI Platform and Peptide Engineering Pipeline.
Peptilogics has 10 investors. Key investors include HHS, CARB-X, Beyond Venture Partners, Presight Capital, and Founders Fund.
Peptilogics operates through Peptilogics, Inc..